Autoinjectors to 2026

$3,850.00

Category:

Description

The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. But suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices – devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass